Trending topics from trusted journalism, transformed into structured debates. Unlike our community discussions, these are automatically curated from breaking news to spark timely, nuanced conversation.
News Discussions are automatically generated from trending stories in real-time. Explore Discussions shows community-created topics on any subject. Both use the same structured debate format, but News focuses on current affairs.
We aggregate stories from these reputable sources to ensure balanced, quality coverage:
The risk level remains high at the regional level and low worldwide, said Tedros Adhanom Ghebreyesus
The bill would allow assisted dying for terminally ill adults who meet strict criteria
The Health Secretary urged the public to only use A&E in genuine emergences
The cost of Obamacare coverage is due to rise by a median of 14% next year, according to a new analysis, marking further turmoil for the law's marketplaces. Why it matters: It would mark the second straight year of double-digit premium increases in the individual market. Customers could be on the hook for thousands of more dollars in costs, worsening the health affordability crisis. The big picture: Insurers blame the hikes on rising costs of health care services and the expiration of enhanced Affordable Care Act subsidies, per the KFF analysis of 77 health plans' preliminary rate filings in 16 states and the District of Columbia. Some enrollees will get subsidies that would cushion the blow, but those who make more than 400% of the federal poverty level, or about $64,000 for a single person, won't qualify.Higher premiums also drive up the government's cost of subsidizing coverage for poorer individuals in the marketplace. Zoom in: The higher out-of-pocket costs are motivating some healthier enrollees, who are more price sensitive, to drop their coverage. That, in turn, makes the overall pool of enrollees sicker and more expensive to care for, causing an increase in overall premiums. Insurers estimate that the sicker risk pool drove premiums up by roughly four percentage points this year and expect a similar increase in 2027.While costs rise, the market is shrinking: Affordable Care Act enrollment already is down by about 3 million people year over year, to 19.2 million, according to federal data released last month. What they're saying: "When you see a decline in enrollment coupled with such a big spike in premiums, neither of those are exactly comforting signs," said Emma Wager, a senior policy analyst for KFF's Program on the ACA. Still, she added, "for now the market is holding strong" overall. The total of 19 million enrollees is still more than any year before 2024. Democrats are seizing on the enrollee drop-off as a campaign issue and blaming Republicans for
More money and resources needed as Ebola spread outpases response, says Africa’s top public health body
Today's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance
States argue the rules will make it too hard for people to get the Medicaid coverage they're entitled too
Nature, Published online: 30 June 2026; doi:10.1038/s41586-026-10837-5 Vaccination elicits HIV broadly neutralizing antibodies in primates
Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately. WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on the available evidence, while ensuring they meet minimum international standards and address the needs of low- and middle-income countries. Through this mechanism, WHO aims to accelerate access to reliable diagnostic tools for early case detection, timely clinical care, disease surveillance and effective outbreak response. The EUL also supports United Nations procurement agencies and governments in making informed decisions about the procurement and use of these products in public health emergency settings. "Public health emergencies require not only speed, but also confidence that the health products being used meet standards for quality, safety and performance," said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. "During a fast-moving outbreak, timely access to quality-assured diagnostic tests can make a critical difference in containing transmission. Through this Emergency Use Listing, WHO is helping countries access trusted diagnostic tools more rapidly so that they can respond more effectively.” On 17 May 2026, WHO Director-General Dr Tedros Adhanom Ghebreyesus declared a public health emergency of international concern over the outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo, with cases in Uganda. Less than two weeks later, WHO launched a call for manufacturers of IVDs for Bundibugyo virus to submit Expressions of Interest for Emergency Use Listing. The listing comes at a critical time as countries respond to the largest recorded outbreak of Ebola disease caused by BDBV, which continu
Scientists say there is a powerful opportunity to save lives because nearly 40% of cancers are preventable
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates the first stages of human development,…
Robert F. Kennedy Jr. has a very different approach to food than to vaccines